04-Jan-2005 - Roche Holding AG

Bayer Consumer Care Operates combined Business January 1

Bayer has closed the acquisition of Roche Consumer Health. From January onwards, the Roche Consumer Health business will become part of the Bayer HealthCare Consumer Care Division, turning Bayer into a leading global over-the-counter (OTC) consumer health organization. The transaction includes the global business of Roche Consumer Health and includes the five Roche Consumer Health production sites in Grenzach (Germany), Gaillard (France), Pilar (Argentinia), Casablanca (Marocco), and Jakarta (Indonesia). Following the merger, Bayer now ranks among the top three OTC consumer health organizations in the world. "Our vision is to become the best consumer health and wellness company. We know that this is an ambitious, but realistic aspiration", explains Gary S. Balkema, President Consumer Care, adding, "As a combined company, we have many trusted brands such as Aspirin®, Aleve®, Rennie®, Alka-Seltzer®, Bepanthen®, Canesten®, Supradyn® and One-A-Day® which provide a strong foundation for growth in the major OTC segments."

Bayer HealthCare Consumer Care is now present in more than 120 countries and the acquisition has made the division a leader in Europe, has extended its top position in Latin America and has reinforced the company's business in the US and Asia-Pacific.

Facts, background information, dossiers
  • Bayer
  • Roche
  • Bayer HealthCare
More about Roche
  • News

    Roche to Acquire Ventana for $89.50 per share

    Roche and Ventana Medical Systems announced that they have signed a definitive merger agreement. Under the terms of the agreement, Roche will increase the purchase price in the tender offer for Ventana common shares to $89.50 per share in cash (or an aggregate of approximately $3.4 billion ... more

    Beckman Coulter Licenses Roche`s Real Time PCR Patent Portfolio

    Beckman Coulter, Inc. has acquired an In Vitro Diagnostics product license to all real-time polymerase chain reaction (PCR) patents and pending patent applications owned or controlled by Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd, Basel, Switzerland. Beckman Coulter will pay ... more

    PPG enters azide chemistry field with process step for Tamiflu

    PPG Industries is entering the field of azide chemistry with the announcement that Roche has selected the company to perform a key process step in the manufacture of the active ingredient for Tamiflu® antiviral pharmaceutical. PPG is one of several companies that will collaborate in the pro ... more

More about Bayer HealthCare
  • News

    After a good third quarter: Bayer confirms Group outlook

    The Bayer Group achieved further sales growth and significantly increased earnings in the third quarter of 2011. “It was a good quarter for Bayer,” Management Board Chairman Dr. Marijn Dekkers said Thursday at the presentation of the interim report. He described the continuing growth moment ... more

    Bayer off to a successful start to 2011

    The Bayer Group got off to a successful start to 2011. “All three subgroups contributed to the strong start to the year with sales and earnings increases,” Bayer CEO Dr. Marijn Dekkers explained on Thursday when the company’s first-quarter results were released. He was especially pleased at ... more

    Bayer focuses resources on growth and innovation

    Bayer plans to invest its resources even more systematically in growing the company and enhancing its innovative capability. The focus will be on researching, developing and marketing new products, particularly in HealthCare and CropScience, and on expanding activities in the emerging marke ... more